4.7 Letter

Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 72, Issue 19, Pages 2408-2409

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.07.097

Keywords

-

Funding

  1. National Institutes of Healthfunded Cardiothoracic Surgery Trials Network [5U01HL088953-05]
  2. National Institutes of Health TL-1 clinical and translational science award (National Center for Advancing Translational Sciences) [1UL1-TR001117-01]
  3. National Heart, Lung, and Blood Institute [F32HL132460-02]
  4. American Heart Association
  5. Amgen
  6. National Heart, Lung, and Blood Institute
  7. Novartis

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available